Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks-Reference-Cited by-同舟云学术

Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks

Published:2023-10 Issue:16 Volume:82 Page:1565-1578
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Yang Seokhun,Kang Jeehoon,Park Kyung Woo,Hur Seung-Ho,Lee Nam Ho,Hwang Doyeon,Yang Han-Mo^ORCID,Ahn Hyo-Suk,Cha Kwang Soo,Jo Sang-Ho^ORCID,Ryu Jae Kean,Suh Il-Woo,Choi Hyun-Hee,Woo Seong-Ill,Han Jung-Kyu^ORCID,Shin Eun-Seok^ORCID,Koo Bon-Kwon,Kim Hyo-Soo^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Lawton;J Am Coll Cardiol,2022

2. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur Heart J,2021

3. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial;Koo;Lancet,2021

4. Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study;Kang;Circulation,2023

5. Relative impact of clinical risk versus procedural risk on clinical outcomes after percutaneous coronary intervention;Kang;Circ Cardiovasc Interv,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in targeted therapy for inflammatory vascular diseases;Journal of Controlled Release;2024-08

2. Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome;Circulation;2024-07-23

3. Optimal antiplatelet therapy after revascularization of left subclavian artery during TEVAR;Journal of Cardiothoracic Surgery;2024-06-28

4. Blocking the TRAIL-DR5 Pathway Reduces Cardiac Ischemia–Reperfusion Injury by Decreasing Neutrophil Infiltration and Neutrophil Extracellular Traps Formation;Cardiovascular Drugs and Therapy;2024-06-20

5. Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure;Cells;2024-05-17